KOR

e-Article

Head-to-Head Comparison of FDG and Radiolabeled FAPI PET: A Systematic Review of the Literature.
Document Type
Article
Source
Life (2075-1729). Sep2023, Vol. 13 Issue 9, p1821. 27p.
Subject
*PERITONEAL cancer
*RADIOPHARMACEUTICALS
*POSITRON emission tomography
*NUCLEAR medicine
Language
ISSN
2075-1729
Abstract
FAPI-based radiopharmaceuticals are a novel class of tracers, mainly used for PET imaging, which have demonstrated several advantages over [18F]FDG, especially in the case of low-grade or well-differentiated tumors. We conducted this systematic review to evaluate all the studies where a head-to-head comparison had been performed to explore the potential utility of FAPI tracers in clinical practice. FAPI-based radiopharmaceuticals have shown promising results globally, in particular in detecting peritoneal carcinomatosis, but studies with wider populations are needed to better understand all the advantages of these new radiopharmaceuticals. [ABSTRACT FROM AUTHOR]